Published in J Neurol Sci on October 01, 1992
Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2007) 1.25
Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol (2013) 0.92
Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study. J Neurol (1998) 0.86
Positron emission tomography imaging in neurological disorders. J Neurol (2012) 0.77
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA (1995) 13.37
Silent ischemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia. Ann Intern Med (1996) 6.11
Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet (2001) 5.09
A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care (1994) 5.02
Brain activity during stimulus independent thought. Neuroreport (1996) 4.00
The logopenic/phonological variant of primary progressive aphasia. Neurology (2008) 3.95
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage (2002) 3.88
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke (2001) 3.58
Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain (1990) 3.54
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. Lancet Neurol (2009) 3.37
Localization of grasp representations in humans by PET: 1. Observation versus execution. Exp Brain Res (1996) 2.80
Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology (1997) 2.77
Brain activity during observation of actions. Influence of action content and subject's strategy. Brain (1997) 2.73
White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry (2002) 2.72
A cultural effect on brain function. Nat Neurosci (2000) 2.69
Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science (2001) 2.52
Central nervous pathways mediating angina pectoris. Lancet (1994) 2.38
The anatomy of unilateral neglect after right-hemisphere stroke lesions. A clinical/CT-scan correlation study in man. Neuropsychologia (1986) 2.35
Investigations of the functional anatomy of attention using the Stroop test. Neuropsychologia (1993) 2.35
The role of the right hemisphere in the interpretation of figurative aspects of language. A positron emission tomography activation study. Brain (1994) 2.29
Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology (2001) 2.24
Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord (2009) 2.13
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology (2004) 2.07
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Neurology (2011) 2.06
Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain (2000) 2.06
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects. Neurology (2004) 2.04
Default-mode network dysfunction and cognitive impairment in progressive MS. Neurology (2010) 2.03
Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (2001) 2.00
Mapping motor representations with positron emission tomography. Nature (1994) 2.00
Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol (2000) 1.99
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol (2011) 1.93
Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol (2000) 1.88
Cognitive and psychosocial features of childhood and juvenile MS. Neurology (2008) 1.85
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology (2010) 1.85
Paraplegia following coeliac plexus block. Pain (1993) 1.85
Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke (1999) 1.80
Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study. Neurology (2009) 1.78
Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes". Neurology (2001) 1.76
Correlation of multiple sclerosis measures derived from T2-weighted, T1-weighted, magnetization transfer, and diffusion tensor MR imaging. AJNR Am J Neuroradiol (2001) 1.75
The bilingual brain. Proficiency and age of acquisition of the second language. Brain (1998) 1.75
Anatomical variability in the cortical representation of first and second language. Neuroreport (1997) 1.74
Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology (1996) 1.74
The contribution of voxel-based morphometry in staging patients with mild cognitive impairment. Neurology (2006) 1.72
Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol (1994) 1.72
Headache attributed to infection: observations on the IHS classification (ICHD-II). Cephalalgia (2006) 1.69
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. Neurology (2011) 1.68
Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke (2000) 1.66
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis. Neurology (1999) 1.65
A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients. J Neurol Neurosurg Psychiatry (2009) 1.64
Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology (2008) 1.63
Unawareness of disease following lesions of the right hemisphere: anosognosia for hemiplegia and anosognosia for hemianopia. Neuropsychologia (1986) 1.63
Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain (2003) 1.60
A prospective study of cerebral ischemia in the young. Analysis of pathogenic determinants. The National Research Council Study Group. Stroke (1993) 1.59
Serial observations on the pathophysiology of acute stroke. The transition from ischaemia to infarction as reflected in regional oxygen extraction. Brain (1983) 1.58
Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue. AJNR Am J Neuroradiol (2011) 1.58
Denaturing gradient gel electrophoresis analysis of the 16S rRNA gene V1 region to monitor dynamic changes in the bacterial population during fermentation of Italian sausages. Appl Environ Microbiol (2001) 1.57
Brain abnormalities underlying altered activation in dyslexia: a voxel based morphometry study. Brain (2005) 1.55
The influence of pregnancy on relapses in multiple sclerosis: a cohort study. Acta Neurol Scand (1991) 1.55
Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke (1999) 1.55
Electrophysiological and MRI evaluation of neurological involvement in Behçet's disease. J Neurol Neurosurg Psychiatry (1989) 1.54
Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis. AJNR Am J Neuroradiol (1999) 1.54
Unilateral neglect, representational schema and consciousness. Brain (1979) 1.52
Impedance measurements to study the antimicrobial activity of essential oils from Lamiaceae and Compositae. Int J Food Microbiol (2001) 1.52
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology (2008) 1.50
Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. AJNR Am J Neuroradiol (1992) 1.50
Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology (1986) 1.48
In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain (2007) 1.48
Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage (1999) 1.47
What insights have new imaging techniques given into aggressive forms of MS--different forms of MS or different from MS? Mult Scler (2008) 1.45
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology (2010) 1.44
Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol (1998) 1.44
Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis. J Neurol Neurosurg Psychiatry (2000) 1.43
IFCN standards for digital recording of clinical EEG. International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol (1998) 1.43
Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology (1999) 1.43
Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology (2001) 1.42
Abnormal cervical cord function contributes to fatigue in multiple sclerosis. Mult Scler (2012) 1.42
The "mirror-neuron system" in MS: A 3 tesla fMRI study. Neurology (2007) 1.42
Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J Immunol (1999) 1.42
Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage (2002) 1.41
Fixed dystonia unresponsive to pallidal stimulation improved by motor cortex stimulation. Neurology (2007) 1.40